Published in Women's Health Weekly, February 7th, 2008
"These trial results represent a significant accomplishment for Vyteris in demonstrating that our delivery system are capable of achieving therapeutic levels of a peptide without using any needles," said Timothy J. McIntyre, chief executive officer of Vyteris....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly